Stock-Based Compensation - Schedule of Option and Appreciation Rights Activity (Details)	12 Months Ended
	Dec. 31, 2023 $ / shares shares
2023 Inducement Plan
Stock Options & SARs
Outstanding (in shares) | shares	0
Granted (in shares) | shares	422,800
Exercised (in shares) | shares	0
Canceled (in shares) | shares	0
Outstanding (in shares) | shares	422,800
Shares exercisable at end of year (in shares) | shares	0
Weighted- Average Exercise Price
Outstanding at beginning of year (in usd per share) | $ / shares	$ 0
Granted (in usd per share) | $ / shares	10.67
Exercised (in usd per share) | $ / shares	0
Canceled (in usd per share) | $ / shares	0
Outstanding at end of year (in usd per share) | $ / shares	10.67
Shares exercisable at end of year (in usd per share) | $ / shares	$ 0
2015 Plan
Stock Options & SARs
Outstanding (in shares) | shares	4,053,290
Granted (in shares) | shares	1,021,596
Exercised (in shares) | shares	(9,483)
Canceled (in shares) | shares	(278,361)
Outstanding (in shares) | shares	4,787,042
Shares exercisable at end of year (in shares) | shares	3,436,339
Weighted- Average Exercise Price
Outstanding at beginning of year (in usd per share) | $ / shares	$ 46.07
Granted (in usd per share) | $ / shares	7.04
Exercised (in usd per share) | $ / shares	6.07
Canceled (in usd per share) | $ / shares	41.38
Outstanding at end of year (in usd per share) | $ / shares	38.10
Shares exercisable at end of year (in usd per share) | $ / shares	$ 41.51
2005 Plan
Stock Options & SARs
Outstanding (in shares) | shares	63,725
Granted (in shares) | shares	0
Exercised (in shares) | shares	0
Canceled (in shares) | shares	(5,450)
Outstanding (in shares) | shares	58,275
Shares exercisable at end of year (in shares) | shares	58,275
Weighted- Average Exercise Price
Outstanding at beginning of year (in usd per share) | $ / shares	$ 112.94
Granted (in usd per share) | $ / shares	0
Exercised (in usd per share) | $ / shares	0
Canceled (in usd per share) | $ / shares	39.70
Outstanding at end of year (in usd per share) | $ / shares	119.79
Shares exercisable at end of year (in usd per share) | $ / shares	$ 119.79